Pyridoxal phosphate

N/A

Report date: 2023/11/27 15:01:52
NME

Base Information

Drug NamePyridoxal phosphate
Drug Alias Name吡哆醛磷酸盐PLP, P5PPyridoxal 5'-phosphate吡哆醛磷酸Tardoxal +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic P2 receptor antagonists
TargetsPurinergic P2 receptor
Therapy Area/IndicationsPyridoxamine 5-Prime-Phosphate Oxidase DeficiencyDepressionVitamin B 6 Deficiency +[9] 
Global Approved IndicationsVitamin B 6 Deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1961/12/01
Country/TerritoryCanadaUnited StatesAustralia +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMedicure Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedicure IncNational Institute Of Mental Health (Nimh)Tsuruhara pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPyridoxamine 5-Prime-Phosphate Oxidase DeficiencyDepressionVitamin B 6 Deficiency
Inactive IndicationsMetabolic SyndromeDiabetes Mellitus, Type 2Reperfusion Injury +[6] 

Other Information

ATC CodeA11HA06
Related LinksWikipediaDrugBankKEGG